Hispanic/Latino and Non-Hispanic BlAck Patients Treated With niRaparib and Abiraterone Acetate Plus Prednisone for Metastatic hOrmone Sensitive Prostate Cancer With Deleterious Homologous recombinatioN Repair Alterations: a Phase II, Open Label studY

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06392841

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:00.447208+00:00

Published At

2026-04-08T00:00:00+00:00

Record Updated At

2026-04-08

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Metastatic Hormone-sensitive Prostate Cancer (mHSPC)", "Deleterious HRR Gene Mutation", "BRCA1 Gene Mutation", "BRCA2 Gene Mutation", "BRIP1 Gene Mutation", "CHEK2 Gene Mutation", "FANCA Gene Mutation", "PALB2 Gene Mutation", "RAD51B Gene Mutation", "RAD54L Gene Mutation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-08"

protocolSection.identificationModule.nctId

"NCT06392841"

protocolSection.identificationModule.officialTitle

"Hispanic/Latino and Non-Hispanic BlAck Patients Treated With niRaparib and Abiraterone Acetate Plus Prednisone for Metastatic hOrmone Sensitive Prostate Cancer With Deleterious Homologous recombinatioN Repair Alterations: a Phase II, Open Label studY"

protocolSection.statusModule.overallStatus

"WITHDRAWN"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (protocolSection.conditionsModule.conditions)
• Deleterious HRR Gene Mutation (protocolSection.conditionsModule.conditions)
• BRCA1 Gene Mutation (protocolSection.conditionsModule.conditions)
• BRCA2 Gene Mutation (protocolSection.conditionsModule.conditions)
• BRIP1 Gene Mutation (protocolSection.conditionsModule.conditions)
• CHEK2 Gene Mutation (protocolSection.conditionsModule.conditions)
• FANCA Gene Mutation (protocolSection.conditionsModule.conditions)
• PALB2 Gene Mutation (protocolSection.conditionsModule.conditions)
• RAD51B Gene Mutation (protocolSection.conditionsModule.conditions)
• RAD54L Gene Mutation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.